Biotechnology Flashcards
White biotech
Use of living organisms or their derivatives to make industrial products
Chemicals
AAs
Vitamins
Enzymes
Industrial chemical production
Acetic acid - fermentation of ethanol or methanol by microbes - 200,000 tonnes produced annually
Butanol - From petroleum or fermentation - used in plastics, paint, resins and brake fluid
Lactic acid - Half of lactic acid in Europe is made by microbes - rest is chemical - used as acidifier - preservative in plastics
Enzymes
traditionally obtained from microorganisms, plants and animals (amylase/pepsin/rennet/trypsin/lipases/proteases)
Enzymes from fungi - Aspergillus oryzae was grown on straw to obtain amylases and proteases - ‘emersed culture’
Produced in large bioreactors after 1950s - submerged culture - high yields/cheap/continuous
Uses of enzymes
Pectinases - break down pectin in manufacture of fruit juice and baby food
Proteases - many uses including in leather tanning
Phytases - added to animal feed to enable digestion of phosphate
Substillsin - detergent
Alkaline proteases, amylases and lipases - detergent
Immobilised enzymes
Enzymes that are fixed in a gel or to a membrane
recyclable
Increased stability
Absent from end product
Lower production costs
Glucose isomerase
Immobilised enzyme
converts glucose into fructose
isolated from streptomyces
Immobilisation successfully increased fructose yield by 42% and reduced production cost by 40%
Red biotechnology
Health related
Biopharmaceuticals
Recombinant proteins
Vaccines
Stem cells
Animal models
Gene therapy
Recombinant proteins
Over 100 recombinant proteins are in use:
50 antibodies - $50 billion
Insulin - $16 billion
Blood clotting factors - $16 billion
Others - $25
Main uses:
Replacement for missing or defective proteins
Inhibition of infectious agents
Insulin production in E. coli
Type 1 diabetes - lack of insulin
High blood sugar
Gene for insulin production put into plasmid - E. coli take up plasmid and replicate
Subunit vaccines
Fragments from the pathogen
Developed before recombinant DNA tech
Pathogens could be grown in liquid culture and secreted proteins were used in the vaccine
Hep B was the first example
Inactivated vaccines
Killed pathogen
Hep A, influenza. rabies
Can not be isolated or cultured in vitro or are too expensive to culture
Risk of infection if alive
Attenuated vaccines
Live, weakened pathogens - no longer express toxin gene
Can be a natural or GM mutant
Safer to produce but need a lot of research to identify the toxic genes
Risk they can revert to pathogenic strain
Sequence genomes of pathogens to develop new vaccines
Sequence pathogen genomes to determine which proteins are responsible for the immune response
Use viral genomes to develop new vaccines
clone genes of interest into a plasmid and insert into vaccine genome
Recombinant vaccinia virus as a vaccine against smallpox or influenza e.g.
DNA based vaccines
Add the gene encoding the antigen into plasmid
Bind the DNA to a charged particle and inject
DNA will bind with genomic DNA particles and the antigen will be expressed temporarily - triggering a localised immune response
cheaper to make and easier to store
first done in 2005 against Wests Nile virus
Edible vaccines
Can express antigens in plants and then eat the plants
GM potatoes containing Hep B vaccines are in trials
Have to eat enough of it and had to be raw
Stem cells
Potency:
totipotent cells can differentiate into all cell lineages to regenerate a whole organism - only embryonic stem cells can do this in mammals
Pluripotent cells are capable of forming all the cell lineages within an embryo but not extraembryonic lineages
Mulitpotent cells have the potential to differentiate into many, but not all, cell lineages